This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Discover which Aristocrats ETF delivers the best value by fee and why cost matters for long-term returns. Learn quick tips to compare expense ratios and pick the right fund.
25,968 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
MARA Holdings sold roughly 15,133 BTC for $1.1 billion to buy back convertible notes and trim debt, a move that reduc...
A glamorous red-carpet moment offers more than style tips. This piece breaks down budget-smart wardrobe decisions, co...
Ripple has lined up a wave of partnerships with global banks in 2026, but XRP prices haven’t reflected the wins. Here...
Regulators and banks frame XRP's path as traders debate a remote target. This report lays out what would be required ...
Billionaire Mark Cuban says crypto has disappointed him, selling most of his Bitcoin, while Ethereum holds some appea...
News outlets report intensified talks of a SpaceX-Tesla merger that would forge a $3.4 trillion powerhouse. The plan ...
As 2026 approaches, two semiconductor giants chart divergent paths: TSMC powers AI chips through its foundry leadersh...
Ethereum briefly stalls as a major corporate ETH buy tests the market. BitMine Immersion Technologies added a large c...
A recent insider move at Precigen has many investors asking if a CFO’s share sale signals trouble. This deep-dive bre...
A French server hardware maker slid more than 40% after a short-seller report alleging a fraudulent U.S. structure. T...
Lucid's stock sits near a critical pricing zone as its balance sheet frays and dilution fears mount, even as producti...